Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia.

Michael L. Ganz,Ameya Chavan,Rahul Dhanda,Michael Serbin,Charles Yonan

Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia.

2021

Michael L. Ganz
Ameya Chavan
Rahul Dhanda
Michael Serbin
Charles Yonan

To evaluate clinical and economic outcomes associated with valbenazine compared with deutetrabenazine in patients with tardive dyskinesia (TD) using a model that accounts for multiple dimensions of...

Keywords:

Tardive dyskinesia
Clinical Global Impression
Deutetrabenazine
Clinical trial
cost effectiveness
Antipsychotic
Abnormal Involuntary Movement Scale
Valbenazine
Medicine
Pediatrics

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations